Opening the Doors: Where did it start?
For decades, healthcare has thrived on direct-to-consumer (D2C) interactions, where patients are directly engaged with healthcare providers and facilities to access essential services and products. This direct engagement has been fundamental to the healthcare industry, enabling the seamless delivery of medical treatments, services, and interventions.
Furthermore, technological advancements have amplified D2C interactions in healthcare. Telemedicine platforms empower patients to consult with healthcare providers remotely, receiving medical advice and treatment recommendations from the comfort of their homes. Online pharmacies enable patients to order prescription medications and healthcare products directly, often with doorstep delivery for added convenience.
The D2C model brings numerous benefits for both patients and healthcare providers. Patients experience enhanced convenience, flexibility, and accessibility to healthcare services, reducing the necessity for unnecessary travel and waiting times. Healthcare providers, on the other hand, can boost patient engagement, streamline service delivery, and improve care coordination through direct interactions.
Despite these advantages, challenges persist in the D2C landscape of healthcare. It’s crucial to ensure the quality and safety of healthcare services and products, necessitating robust regulatory oversight and adherence to industry standards. Additionally, concerns surrounding patient privacy, data security, and healthcare disparities must be addressed to uphold patient interests and promote equitable access to care.
While D2C has been the traditional means of operations, there have been lots of headwinds that have been hitting the industry in the recent past.
The whitespace in the industry:
While there are staggering upticks in tech innovation, the industry has also been facing some white space.
Reports indicate a significant gender divide in the adoption of digital healthcare tools, with women being 75% more likely than men to embrace them. However, it’s striking that only 18% of startups in the female health sector are led by women, leading to a dearth of innovation and trust in the industry.
Gender disparity is evident in interactions with direct-to-consumer (D2C) female wellness companies, with India ranking a low 135th out of 146 nations in the global gender gap report. Approximately 50 million women in India grapple with reproductive health issues, and about 50% suffer from anaemia. Despite these alarming figures, the gap persists due to inadequate brand awareness and campaigns.
Statistics from The Woman Company (TWC) reveals that 70% of its sales originate from Tier-1 cities, underscoring the lack of public awareness and accessibility in rural India.
A one-size fit all approach:
In addition to these, there seems to be a web of issues that have surrounded the ecosystem.
The D2C healthcare industry faces stiff competition, making it tough to stand out. Many companies struggle to differentiate themselves, which leads to high customer acquisition costs and lower profits.
Additionally, there’s a lack of brand awareness among consumers, making it hard for D2C healthcare firms to explain their value.
Scaling operations is another challenge due to limited resources and structural constraints. This leaves many companies unable to meet market demands and stifles their growth.
Trust is lacking in the D2C healthcare sector, mainly due to poor customer experiences and doubts about service quality. Consumers often prefer traditional healthcare channels over online platforms.
Gender differences are also an issue, with D2C healthcare often neglecting women’s unique needs. This can leave female consumers feeling ignored and less likely to engage with these platforms.
Furthermore, one-size-fits-all approaches don’t appeal to consumers looking for personalised healthcare solutions. Without tailored options, D2C healthcare providers risk losing relevance in the market.
Pulse of the people:
To further complement our views, some of our ecosystem founders, on the promise of anonymity voiced their thoughts on the challenges that surround the space:
Founder
“A big hurdle in adopting the D2C model, especially for healthcare products or services, is the lack of knowledge about specific health issues, especially in women’s health. Many women may not have the right information about their health or certain medical conditions, which can lead to delays in seeking appropriate care.In the femtech sector, getting users on board may take longer compared to other industries. People might be cautious about trying new technologies or services.
To overcome this, it’s important to raise awareness, connect with users, and understand their needs. This takes time and requires consistent delivery of value and transparency to build trust. So, the key is to understand and meet the diverse needs of the target audience. This involves ongoing research, gathering feedback, improving products, and being willing to adapt when needed.”
Founder
“Establishing trust is the main challenge for service-oriented wellness businesses. It’s a slow process that requires dedication and a focus on making a real impact. Complicating things further is the lack of strong regulations and the prevalence of misleading claims in the healthcare industry.
When it comes to funding, healthcare service startups usually have a longer and more gradual growth path compared to e-commerce or product-focused startups, which can deter investors. This often leads healthcare startups to shift towards direct-to-consumer approaches, as investors prefer faster growth and scalability.
Unlike product-based startups, service-based healthcare startups face difficulty in measuring outcomes as they don’t always have tangible goals.”
Where are we heading?
In rapidly evolving D2C industries, being the first mover can backfire. Early entrants must build infrastructure and create demand from scratch, which increases the risk of failure due to longer lead times. Conversely, later entrants benefit from established markets and infrastructure, leading to quicker success.
D2C service models often lack the positive network seen in traditional ecommerce platforms, making it harder to reach price equilibrium and navigate market dynamics swiftly.
Unlike ecommerce platforms that quickly reduce information gaps and stabilise prices, D2C brands face challenges in perfecting pricing strategies due to trial and error.
Moreover, D2C service models struggle with differentiation. In crowded markets, brands find it hard to stand out without a unique selling proposition.
However, healthcare startups focusing on services have great potential to improve the sector. They need widespread acceptance from users and investors, which calls for better regulations, standardised protocols, and benchmarks to build trust and stability.
Startups entering this space must establish clear frameworks for development and expansion. Moreover, national-level research institutions, organisations, and universities should support these startups to enhance their credibility and growth opportunities.
Investors should prioritise sustainability and impact when supporting healthcare service startups, aiming for lasting benefits for patients and society.
At the end of the day, the ecosystem should be a winning ground for all the stakeholders!
[Sign up here to never miss these candid conversations delivered straight to your inbox.]
